{
    "2019-02-11": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Exchange Offer",
                        "Sale",
                        "Elanco Stake"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Incyte Down as FDA Extends Review Period of Jakafi for GVHD",
                "features": {
                    "keywords": [
                        "Incyte",
                        "FDA",
                        "Extends",
                        "Review Period",
                        "Jakafi",
                        "GVHD"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Teva (TEVA) to Report Q4 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Teva",
                        "Q4 Earnings",
                        "Report"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}